Skip to main content
Displaying 1 - 12 of 13
Display:
12
24
48
Metabolism, Alcohol & Toxicity
Novo Nordisk: Unfolding the metabolic dysfunction of MASH: exploring the pathophysiology and outcomes (Complete Session)
Webcasts
View
Metabolism, Alcohol & Toxicity
Welcome and Introduction
Webcasts
View
Metabolism, Alcohol & Toxicity
Navigating MASH patient care
Webcasts
View
Metabolism, Alcohol & Toxicity
Panel Discussion (Q & A)
Webcasts
View
Metabolism, Alcohol & Toxicity
Approaching MASH as a metabolic disease to reduce outcomes
Webcasts
View
Metabolism, Alcohol & Toxicity
Linking the pathophysiology of MASH to its metabolic comorbidities
Webcasts
View
Metabolism, Alcohol & Toxicity
Q&A and closing remarks
Webcasts
View
Metabolism, Alcohol & Toxicity
Novo Nordisk: Navigating MASH patient care (Complete Session)
Webcasts
View
Metabolism, Alcohol & Toxicity
Why we need to talk about NASH
Webcasts
View
Metabolism, Alcohol & Toxicity
Hepatic consequences of metabolic dysregulation: NAFLD and NASH
Webcasts
View
Metabolism, Alcohol & Toxicity
Looking ahead: how to identify high-risk patients
Webcasts
View
Metabolism, Alcohol & Toxicity
Navigating the NASH healthcare system: global insights and challenges (panel discussion and Q&A)
Webcasts
View
Pagination
Current page
1
Page
2
Next page
next ›
Last page
Last »
©2019 - EASL. All Rights Reserved. Powered by
Enovation
.
Footer menu
Content Access policy
Privacy Policy
Cookie Policy